Resignation of Himanshu Agarwal as Executive Director and Chief Financial Officer of the company w.e.f…
As filed · Cohance Lifesciences Limited has informed the Exchange regarding Resignation of Himanshu Agarwal as Executive Director and Chief Financial Officer of the company w.e.f. September 13, 2026.
What happened
FactCohance Lifesciences Limited has informed the Exchange regarding Resignation of Himanshu Agarwal as Executive Director and Chief Financial Officer of the company w.e.f. his duties with effect from the close of business hours on 13 September 2026. Corporate Office: 202, A-Wing, Galaxy Towers, Plot No.l, Hyderabad.
Why it matters
CapitSignal interpretationThe CEO/MD sets the strategy that existing guidance was built on; a change puts that guidance up for revision.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnOur medium-term objective is to qualify approximately two new products each year, combining opportunities with the existing anchor customer and new customer across Europe and Japan.
The photochromic portfolio remained balanced, supported by our established chemistry platforms and customer relationships.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Whether previously stated targets are reaffirmed
- Internal promotion versus external hire
- Any change to capital-allocation plans
- Our vision of a US$1 billion business by 2030 remains there. We are committed to reach there. (management committed by FY30)
- our vision for US$1 billion by 2030. (management committed by FY30)
Evidence
- Cohance Lifesciences Limited has informed the Exchange regarding Resignation of Himanshu Agarwal as Executive Director and Chief Financial Officer of the company w.e.f. September 13, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- CEO_MD_CHANGE base 62; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%